Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-011170
Filing Date
2018-08-08
Accepted
2018-08-08 16:18:43
Documents
75
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 445058
2 ex31-1.htm EX-31.1 11279
3 ex31-2.htm EX-31.2 11315
4 ex32-1.htm EX-32.1 6919
5 ex32-2.htm EX-32.2 7328
  Complete submission text file 0001493152-18-011170.txt   3401366

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE xtnt-20180630.xml EX-101.INS 559965
7 XBRL SCHEMA FILE xtnt-20180630.xsd EX-101.SCH 43988
8 XBRL CALCULATION FILE xtnt-20180630_cal.xml EX-101.CAL 76194
9 XBRL DEFINITION FILE xtnt-20180630_def.xml EX-101.DEF 144526
10 XBRL LABEL FILE xtnt-20180630_lab.xml EX-101.LAB 319634
11 XBRL PRESENTATION FILE xtnt-20180630_pre.xml EX-101.PRE 254503
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 181001606
SIC: 2836 Biological Products, (No Diagnostic Substances)